MAIN ARTICLE
An unexpected sample changes the research question
Scientific leads sometimes arise when a result refuses to fit the working hypothesis. Studying samples collected for Alzheimer’s research, Kanta Horie, Chihiro Sato and colleagues encountered a person with an unexpectedly high eMTBR-tau243 reading. Autopsy records showed no Alzheimer’s pathology in that case, but they did show advanced CTE. The finding suggested that a marker associated with Alzheimer’s might also reflect a broader class of neurodegenerative disorders.
The researchers examined additional stored tissue and fluid samples, ultimately studying blood collected from 11 donors whose CTE was established through postmortem examination. The overall case-control project included 229 participants drawn from multiple repositories and disease groups. That larger total provides valuable context, but it does not erase the small size of the CTE blood subgroup or supply the evidence required to approve a clinical diagnostic test.
What tau reveals—and what it cannot tell us
Tau is a protein that normally helps maintain the internal scaffolding of nerve cells. In some neurological diseases it changes and forms damaging tangles. eMTBR-tau243 is a measurable tau fragment that researchers can detect in blood or cerebrospinal fluid.

















